tiprankstipranks
Trending News
More News >
AlzeCure Pharma AB (DE:AC6)
FRANKFURT:AC6
Germany Market

AlzeCure Pharma AB (AC6) Income Statement

Compare
2 Followers

AlzeCure Pharma AB Income Statement

Last quarter (Q4 2025), AlzeCure Pharma AB's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q4, AlzeCure Pharma AB's net income was kr-17.74M. See AlzeCure Pharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profit
kr -1.27Mkr -293.00Kkr -476.00Kkr -570.00Kkr -576.00K
Operating Expenses
kr 48.10Mkr 36.14Mkr 37.83Mkr 56.57Mkr 78.14M
Depreciation and Amortization
kr 1.27Mkr 293.00Kkr 476.00Kkr 570.00Kkr 576.00K
EBITDA
kr -48.10Mkr -35.70Mkr -37.87Mkr -55.67Mkr -77.20M
Operating Income
kr -49.37Mkr -36.45Mkr -38.26Mkr -56.44Mkr -77.93M
Other Income/Expenses
kr 1.70Mkr 1.22Mkr 1.09Mkr 203.00Kkr 145.00K
Pretax Income
kr -47.67Mkr -35.23Mkr -37.17Mkr -56.24Mkr -77.78M
Net Income
kr -47.65Mkr -35.23Mkr -37.17Mkr -56.04Mkr -77.78M
Per Share Metrics
Basic EPS
kr -0.47kr -0.46kr -0.60kr -1.18kr -1.98
Diluted EPS
kr -0.47kr -0.46kr -0.60kr -1.18kr -1.98
Weighted Average Shares Outstanding
100.50M 76.59M 61.95M 47.70M 39.32M
Weighted Average Shares Outstanding (Diluted)
100.50M 77.15M 62.09M 47.70M 39.32M
Currency in SEK

AlzeCure Pharma AB Earnings and Revenue History